Ascorbic acid, alpha-tocopherol, and betacarotene reduce oxidative stress and proinflammatory cytokines in mononuclear cells of Alzheimer's disease patients

Nutritional Neuroscience

Volumn 15, Issue 6, 2012, Pages 244-251

  de Oliveira, Barbara Fonseca ^a   Veloso, Clara Araujo ^a   Nogueira Machado, José Augusto ^b   de Moraes, Edgar Nunes ^a   dos Santos, Rodrigo Ribeiro ^a   Cintra, Marco Túlio Gualberto ^a   Chaves, Míriam Martins ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Santa Casa de Belo Horizonte (SCBH)   (Brazil)

Author keywords

Alzheimer's disease; Antioxidants; Mononuclear cells; Oxidativestress; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT;

ADULT; AGED; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; DRUG EFFECTS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-TOCOPHEROL; ALZHEIMER DISEASE; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-4; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84871213357     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/1476830512Y.0000000019     Document Type: Article

References (42)

1. Spirduso WW, Francis KL, Macrae PG. Physical dimensions of aging. Human Kinetics, United States of America, 2nd ed. 2005.
2. Denham H. The aging process. Proc Nat Acad Sci 1981;78: 7124-8.
3. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443:787-95.
4. Luigi AD, Fragiacomo C, Lucca U, Quadri P, Tettamanti M, Simoni MGD. Inflammatory markers in Alzheimer's disease and multi-infarct dementia. Mech Ageing Dev 2001;122: 1985-95.
5. Streit WJ, Conde JR, Harrison JK. Chemokines and Alzheimer's disease. Neurobiol Aging 2001;22:909-13.
6. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997;82:291-5.
7. Moraes EN, Moraes FL. Coleção guia de bolso em geriatria e gerontologia Incapacidade cognitiva: Abordagens diagnósticas e terapêuticas das demências no idoso. Folium Editorial 2010; 117:117-32.
8. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: A standatized measure of biological and psychosocial function. JAMA 1963; 185:914-9.
9. Brucki SMD, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Sugestões de uso do Mini-exame do estado mental no Brasil. Arquivo Neuropsiquiatria 2003;61:777-81.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. American Psychiatric Association, United States of America, 2000.
11. McKhann G, Drachman D, Folstein M, Katzman M, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
12. WHO Technical Report Series. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Geneva: World Health Organization; 2000.
13. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2011;34(1):S11-S61.
14. Kris-Etherton PM, Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2011;123:2292-333.
15. National Committee for Clinical Laboratory Standards. How to define, determine and utilize reference intervals in the clinical laboratory: Proposed guidelines. 2000; NCCLS document C28-A2.
16. Bicalho HMS, Gontijo MC, Nogueira-Machado JA. A simple technique for simultaneous human leukocytes separation. J Immunol Methods 1981;40:115-116.
17. Bergman M, Salman H, Djaldetti M, Fish L, Punsky I, Bessler H. In vitro immune response of human peripheral blood cells to vitamins C and E. J NutrBiochem 2004;15:45-50.
18. Prabhala RH, Maxey V, Hicks MJ, Watson RR. Enhancement of the expression of activation markers on human peripheral blood mononuclear cells by in vitro culture with retinoids and carotenoids. J Leukoc Biol. 1989;45:249-254.
19. Zhang P, Omaye ST. Beta-carotene and protein oxidation: effects of ascorbic acid and alpha-tocopherol. Toxicology 2000;146: 37-47.
20. Chaves MM, Rocha-Vieira E, Silva RL, Reis AP, Nogueira- Machado JA. Host defenses in the aged: evaluation of the balance between oxidizing species generation and reducing power in phagocyting human granulocytes. Mech Aging Dev 1998;104:103-109.
21. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX study - A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-2242.
22. Bouwens M, Afman LA, Muller M. Fasting induces changes in peripheral blood mononuclear cell gene expression profiles related to increases in fatty acid β-oxidation: functional role of peroxisome proliferator-activated receptor α in human peripheral blood mononuclear cells. Am J Clin Nutr 2004;86: 1515-1523.
23. Soni MG, Thurmond TS, Miller ER, Spriggs T, Bendich A, Omaye ST. Safety of vitamins and minerals: controversies and perspective. Tox Sci 2010;118(2):348-355.
24. Knekt P, Reunanen A, Javinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139(12):1180-1189.
25. Pivi GAK, Silva RV, Juliano Y, Novo NF, Okamoto IH, Brant CQ, et al. A prospective study of nutrition education and oral nutritional supplementation in patients with Alzheimer's disease. Nutr J 2011;10:1-6.
26. Gu Y, Nieves JW, Stern Y, Luchsinger JA, Scarmeas N. Diet and prevention of Alzheimer disease. Arch Neurol 2010;67(6): 699-706.
27. Von Arnim CAF, Gola U, Biesalski HK. More than the sum of its parts? Nutrition in Alzheimer's disease. Nutrition 2010;26: 694-700.
28. Marchasson IB, Beauvieux MCD, Peuchant E, Harston SR, Decamps A, Reignier B, et al. Antioxidant defenses and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 2001;30: 235-241.
29. Rocha NP, Teixeira AL, Coelho FM, Caramelli P, Guimarães HC, Barbosa IG, et al. Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide. Mol Cell Neurosci 2012;49(1):77-84.
30. Szekely CA, Zandi PP. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: The epidemiological evidence. Drug Targets 2010;8:132-139.
31. Masters CL, Selkoe DJ. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harbor Symp Quant Biol 2012;2(5):1-24.
32. Yong WV, Marks S. The interplay between the immune and central nervous systems in neuronal injury. Neurology 2010; 74(1):S9-S16.
33. Mrak RE, Griffin WST. Interleukin-1, neuro inflammation and Alzheimer's disease. Neurobiol Aging 2005;22:903-908.
34. Malm T, Magga J, Koistinaho J. Animal models of Alzheimer's disease: utilization of transgenic Alzheimer's disease models in studies of amyloid beta clearance. Curr Tran Geriatr Gerontol Rep 2012;1(1):11-20.
35. Peck A, Mellins ED. Plasticity of T-cell phenotype and function: the T-helper type 17 example. Immunology 2010;129:147-153.
36. Shalit F, Sredni B, Stern L, Kott E, Huberman M. Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients. Neurosci Lett 1994;174(2):130-132.
37. Jeng KCG, Yang CH, Siu WI, Tsai YS, Liao WJ, Kuo JS. Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults. Am J Clin Nutr 1996;64:960-965.
38. Hartel C, Strunk T, Bucsky P, Schultz C. Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine 2003;27:101-6.
39. Beyaert R, Cuenda A, Berghe WV, Plaisance S, Lee JC, Haegeman G, et al. p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor. EMBO J 1996;15(8):1914-1923.
40. Cindrova-Davies T, Spasic-Boskovic O, Jauniaux E, Charnock-Jones DS, Burton GJ. Nuclear factor-_B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress. Am J Pathol 2007;170(5):1511-1520.
41. Floyd RA, Antioxidants, Oxidative stress, and degenerative neurological disorders. PSEBM 1999;222:237-245.
42. Tan PH, Sagoo P, Chan C, Yates JB, Campbell J, Beutelspacher SC, et al. Inhibition of NF-κB and oxidative pathways in human dendritic cells by antioxidant vitamins generates regulatory T cells. J Immunol 2005;174:7633-7644.